Knowles Corporation · NYSE:KN

Knowles — Q3 2026 Earnings Presentation

14 slides from Knowles's earnings presentation, Oct 22, 2026

  1. Slide 1: 3rd Quarter 2026 Earnings Release Supplemental Information

    10.22.26 3rd Quarter 2026 Earnings Release Supplemental Information

  2. Slide 2: Safe Harbor

    Safe Harbor Forward Looking Statements A number of statements in our presentations, the accompanying slides, and the responses to questions on our conference call discussing our quarterly results may constitute forward-looking statements within the meaning of the safe harbor provisions of the United

  3. Slide 3: Third Quarter Results

    Third Quarter Results Revenue Non-GAAP Diluted EPS* Net Cash Provided by Revenue growth was driven ($M) ($) Operating Activities by strong product demand ($M) across in the four major markets we serve: Medtech, Defense, Industrial, and Electrification. 184.0 44.6 0.38 152.9 0.33 Non-GAAP Diluted EPS

  4. Slide 4: MedTech & Specialty Audio

    SEGMENT PERFORMANCE MedTech & Specialty Audio Revenue Adjusted EBITDA Margin* ($) (%) 43.7 Third quarter revenue 67.0 41.6 growth was driven by higher 64.7 volumes in hearing health shipments. -210 Adjusted EBITDA margin +3.6% was impacted by inventory bps reserves and increased R&D and OPEX spend s

  5. Slide 5: Precision Devices

    SEGMENT PERFORMANCE Precision Devices Revenue Adjusted EBITDA Margin* Revenue growth in the third ($) (%) quarter was driven by increased demand for our 117.0 products across the four 27.5 major markets we serve - 25.7 Medtech, Defense, Industrial 88.2 and Electrification. Adjusted EBITDA margin inc

  6. Slide 6: Fourth Quarter 2026 Outlook

    Fourth Quarter 2026 Outlook GAAP Adjustments Non-GAAP Revenues from continuing operations $180 to $190 million $— $180 to $190 million Diluted earnings per share from $0.31 to $0.35 $0.08 $0.39 to $0.43 continuing operations Net cash provided by operating activities $60 to $70 million $— $60 to $70

  7. Slide 7: Appendix

    « knowles Appendix

  8. Slide 8: Reconciliation of GAAP Financial Measures to Non-GAAP Financial Measures

    Quarter Ended September 30, RECONCILIATION OF GAAP FINANCIAL MEASURES TO NON-GAAP FINANCIAL MEASURES (continuing operations, in millions, except per share amounts) 2026 2025 Revenues $ 184.0 $ 152.9 Gross profit $ 81.3 $ 69.9 Notes Gross profit margin 44.2 % 45.7 % 1. Production transfer costs repre

  9. Slide 9: Reconciliation of GAAP Financial Measures to Non-GAAP Financial Measures

    RECONCILIATION OF GAAP FINANCIAL MEASURES TO NON-GAAP FINANCIAL MEASURES Quarter Ended September 30, (continuing operations, in millions, except per share amounts) 2026 2025 Notes Net earnings $ 21.2 $ 18.0 5. The non-GAAP reconciling adjustments include stock-based compensation expense, Interest ex

  10. Slide 10: Historical Segment Data

    PRECISION DEVICES MEDTECH & SPECIALTY AUDIO HISTORICAL SEGMENT DATA Quarter Ended Quarter Ended September 30, June 30, March 31, December 31, September 30, September 30, June 30, March 31, December 31, September 30, (continuing operations, in millions) 2026 2026 2026 2025 2025 2026 2026 2026 2025 20

  11. Slide 11: Historical Segment Data

    HISTORICAL SEGMENT DATA PRECISION DEVICES MEDTECH & SPECIALTY AUDIO Quarter Ended Quarter Ended September 30, June 30, March 31, December 31, September 30, September 30, June 30, March 31, December 31, September 30, (continuing operations, in millions) 2026 2026 2026 2025 2025 2026 2026 2026 2025 20

  12. Slide 12: Reconciliation of Net Earnings to Adjusted EBITDA

    RECONCILIATION OF NET EARNINGS TO ADJUSTED EBITDA Quarter Ended September 30, June 30, March 31, December 31, Trailing (continuing operations, in millions) 2026 2026 2026 2025 12-months Net earnings $ 21.2 $ 18.4 $ 11.3 $ 25.5 $ 76.4 Interest expense, net 1.6 1.7 1.5 1.8 6.6 Provision for (benefit f

  13. Slide 13: Reconciliation of Net Debt

    RECONCILIATION OF NET DEBT (in millions) September 30, 2026 Current maturities of long-term debt $ — Long-term debt 116.0 Total debt 116.0 Less: Cash and cash equivalents (46.6) Net debt $ 69.4 Net debt $ 69.4 Trailing 12 Month Adjusted EBITDA $ 166.7 Net debt leverage ratio 0.4 x 13

  14. Slide 14: Thank you.

    Thank you. « knowles

Knowles — Q3 2026 Earnings Presentation on 6ix